Abstract Streptococcus pyogenes (Group A Streptococcus; GAS) is exquisitely adapted to
the human host, resulting in asymptomatic infection, pharyngitis, pyoderma, scarlet fever or …

Streptococcus pyogenes,(colloquially named “group A streptococcus”(GAS)), is a pathogen
of public health significance, infecting 18.1 million people worldwide and resulting in …

Hospitals worldwide are facing an increasing incidence of hard-to-treat infections. Limiting
infections and providing patients with optimal drug regimens require timely strain …

Streptococcus pyogenes, also known as Group A Streptococcus (GAS), is a Gram-positive
human-exclusive pathogen, responsible for more than 500 000 deaths annually worldwide …

While the incidence of many diseases has declined in developed countries, regions of the
world with low income and poor infrastructure continue to suffer a high burden of …

Background The unique characteristics of long-term care facilities (LTCFs) including host
factors and living conditions contribute to the spread of contagious pathogens. Control …

Historically, Streptococcus pyogenes (group A streptococci) was first cultured and identified
as the cause of erysipelas by Friedrich Fehleisen in 1883, and it received its species …

Streptococcus pyogenes is one of the Top 10 human infectious disease killers worldwide
causing a range of clinical manifestations in humans. Colonizing a range of ecological …

Background Streptococcus pyogenes is a major cause of severe, invasive infections in
humans. The bacterial pathogen harbors a wide array of virulence factors and exhibits high …

The recently observed increase in invasive Streptococcus pyogenes infections causes
concern in Europe. However, conventional molecular typing methods lack discriminatory …